Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum membrane protein complex subunit 7 (EMC7) is a subunit of the endoplasmic reticulum membrane protein complex (EMC), a multiprotein assembly that facilitates the energy-independent insertion of transmembrane domains (TMDs) into the ER membrane[2][3][1][5][4]. EMC7 forms part of the lumenal module of the EMC together with other subunits, and while it has no enzymatic activity or ligand-binding properties itself, it is crucial for the structural integrity and function of the entire EMC complex. This includes enabling the insertion and accurate folding of tail-anchored membrane proteins and multi-pass integral membrane proteins—many of which are critical for cell signaling and organelle function. Defects in EMC activity, including EMC7, are associated with impaired membrane protein biogenesis and can contribute to various disease states. However, EMC7 itself is not directly addressed as a therapeutic target, nor are drugs known to specifically target EMC7 function[2][3][4][1][5].
Not directly targeted by drugs and thus no defined mechanism for direct pharmacological action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum membrane protein complex subunit 7 (EMC7).